SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-006537
Filing Date
2020-03-23
Accepted
2020-03-23 15:50:06
Documents
19
Period of Report
2020-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 18248
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 30723
3 ex99_1slide1.jpg GRAPHIC 90304
4 ex99_1slide2.jpg GRAPHIC 292096
5 ex99_1slide3.jpg GRAPHIC 157776
6 ex99_1slide4.jpg GRAPHIC 101137
7 ex99_1slide5.jpg GRAPHIC 105859
8 ex99_1slide6.jpg GRAPHIC 111093
9 ex99_1slide7.jpg GRAPHIC 75184
10 ex99_1slide8.jpg GRAPHIC 141632
11 ex99_1slide9.jpg GRAPHIC 136319
12 ex99_1slide10.jpg GRAPHIC 72415
13 ex99_1slide11.jpg GRAPHIC 96738
14 ex99_1slide12.jpg GRAPHIC 136433
15 ex99_1slide13.jpg GRAPHIC 113955
16 ex99_1slide14.jpg GRAPHIC 162507
17 ex99_1slide15.jpg GRAPHIC 72465
18 ex99_1slide16.jpg GRAPHIC 131306
19 ex99_1slide17.jpg GRAPHIC 165724
  Complete submission text file 0001140361-20-006537.txt   3030617
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 20734868
SIC: 2834 Pharmaceutical Preparations